Therefore, several studies have highlighted the resistance mechanism against immunotherapy as a phenomenon in which CD8+ T-cells are either unable to recognize and localize to the tumor or are rendered ineffective despite their seemingly adequate localization [23]. This evidence concerns the gene CD8A and neoplasm.